Home
Madrigal Pharmaceuticals and Akero Therapeutics: After Having No Treatment for NASH, We Now Have Two Products Expected to be Approved

Madrigal Pharmaceuticals and Akero Therapeutics: After Having No Treatment for NASH, We Now Have Two Products Expected to be Approved

Today’s Highlights December 19, 2022

Treatments for NASH
Madrigal Pharmaceuticals (MDGL) is the second company after Akero Therapeutics (AKRO) to . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.
Today’s Highlights
,
December 19, 2022

Other Articles